Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. （開啟新視窗）

Evans WE, Relling MV, Rodman JH, Crom WR, Boyett JM, Pui CH

來源‎: N Engl J Med 1998;338(8):499-505.

檢索‎: PubMed 9468466

DOI碼‎: 10.1056/NEJM199802193380803

https://www.ncbi.nlm.nih.gov/pubmed/9468466 （開啟新視窗）

Childhood cancer and the Jehovah's Witness faith. （開啟新視窗）

Frankel LS, Damme CJ, Eys JV.

來源‎: Pediatrics 1977;60(6):916-21.

檢索‎: PubMed 600607

https://www.ncbi.nlm.nih.gov/pubmed/600607 （開啟新視窗）

Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma. （開啟新視窗）

Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK

來源‎: J Clin Oncol 2004;22(24):4888-92.

檢索‎: PubMed 15611504

DOI碼‎: 10.1200/JCO.2004.02.101

https://www.ncbi.nlm.nih.gov/pubmed/15611504 （開啟新視窗）

Assessment of arsenic trioxide and all-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group AAML1331 Trial. （開啟新視窗）

Kutny MA, Alonzo TA, Abla O, Rajpurkar M, Gerbing RB, Wang YC, Hirsch BA, Raimondi S, Kahwash S, Hardy KK, Hardy S, Meshinchi S, Gamis AS, Kolb EA, Feusner JH, Gregory J Jr

來源‎: JAMA Oncol 2022;8(1):79-87. 

檢索‎: PubMed 34762093

DOI碼‎: 10.1001/jamaoncol.2021.5206

https://pubmed.ncbi.nlm.nih.gov/34762093/ （開啟新視窗）

Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia. （開啟新視窗）

Lou Y, Qian W, Meng H, Mai W, Tong H, Tong Y, Huang J, Jin J.

來源‎: Hematol Oncol 2014;32(1):40-6.

檢索‎: PubMed 23963734

DOI碼‎: 10.1002/hon.2076

https://www.ncbi.nlm.nih.gov/pubmed/23963734 （開啟新視窗）

Acute leukemia in Jehovah's Witnesses: a challenge for hematologists. （開啟新視窗）

Mazza P, Palazzo G, Amurri B, Cervellera M, Rizzo C, Maggi A

來源‎: Haematologica 2000;85(11):1221-2.

檢索‎: PubMed 11064477

https://www.ncbi.nlm.nih.gov/pubmed/11064477 （開啟新視窗）

Autologous and allogeneic stem cell transplant in Jehovah's Witnesses: a single-center experience on 22 patients. （開啟新視窗）

Mazza P, Palazzo G, Minoia C, Amurri B, Pisapia G

來源‎: Bone Marrow Transplant 2016;51(7):1002-3.

檢索‎: PubMed 26950381

DOI碼‎: 10.1038/bmt.2016.29

https://www.ncbi.nlm.nih.gov/pubmed/26950381 （開啟新視窗）

Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. （開啟新視窗）

Mazza P, Prudenzano A, Amurri B, Palazzo G, Pisapia G, Stani L, Pricolo G.

來源‎: Bone Marrow Transplant 2003;32(4):433-6.

檢索‎: PubMed 12900781

DOI碼‎: 10.1038/sj.bmt.1704179

https://www.ncbi.nlm.nih.gov/pubmed/12900781 （開啟新視窗）

Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. （開啟新視窗）

Ruiz-Argüelles GJ, Morales-Toquero A, López-Martínez B, Tarín-Arzaga LD, Manzano C.

來源‎: Bone Marrow Transplant 2005;36(8):715-20.

檢索‎: PubMed 16113672

DOI碼‎: 10.1038/sj.bmt.1705126

https://www.ncbi.nlm.nih.gov/pubmed/16113672 （開啟新視窗）

Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia. （開啟新視窗）

Zwaan CM, Kaspers GJ

來源‎: Br J Haematol 2004;127(3):264-79.

檢索‎: PubMed 15491285

DOI碼‎: 10.1111/j.1365-2141.2004.05167.x

https://www.ncbi.nlm.nih.gov/pubmed/15491285 （開啟新視窗）

Tratamiento de la leucemia aguda linfoblástica con poliquimioterapia sin hemoderivados en niños Testigos de Jehová​. [Treatment of acute lymphoblastic leukemia using combination chemotherapy without blood-derived products in Jehovah's Witness children. （開啟新視窗）

​Tenorio-Guajardo G, Ferrer-Argote VE, Glender-Díaz W, Collazo-Jaloma J

來源‎: Rev Med Hosp Gen Mex 2009;72(1):16-9.

檢索‎: ISSN 0185-1063

https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=21009 （開啟新視窗）